undefined undefined
NaN.000
NaN.00%
Wedbush analyst Laura Chico maintained a Buy rating on PepGen Inc. (PEPG – Rese...
05-15 21:15
PepGen (NASDAQ:PEPG) reported quarterly earnings of $0.56 per share.
05-15 04:33
An advisory committee of the U.S. Department of Health and Human Services is expected to vote this fall on whether to recommend newborns be screened for Duchenne muscular dystrophy, or DMD. The Adviso...
05-10 06:44
Edgewise Therapeutics (NASDAQ:EWTX) has received orphan drug designation from EU regulators for its drug candidate sevasemten in the treatment of Becker muscular dystrophy and Duchenne muscular dystro...
04-23 22:29
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.
04-10 20:11
Aerovate Therapeutics, Inc. (NASDAQ:AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease, today announced that its Board of
03-06 21:11
BOSTON, Feb. 20, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinica...
02-20 09:00
Although U.S. stocks closed sharply lower on Tuesday, there were a few notable insider trades.
02-14 21:28
NRBO收涨67.3%,FDA核准公司肥胖药物进行一期试验;Nextracker隔夜涨幅24.8%,公司业绩超预期>>
02-02 18:23
CRBP隔夜大涨逾35%,获股东增持28.26万股普通股股份;Kura肿瘤学收涨12.1%,公司对白血病联合疗法的研究早期数据积极>>
01-31 19:15